Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?

被引：1
|
作者：
Park, Jihye [1 ,2 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea
来源：
INTESTINAL RESEARCH | 2022年 / 20卷 / 01期
关键词：
NECROSIS FACTOR THERAPY; CROHNS-DISEASE; RISK-FACTORS; SURGERY; VEDOLIZUMAB;
D O I：
10.5217/ir.2021.00170
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [1] VEDOIZUMAB DOES NOT INCREASE PERIOPERATIVE SURGICAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Poylin, Vitaliy Y.
    Cataneo, Jose
    Pastrana, Jonathan
    Feuerstein, Joseph D.
    GASTROENTEROLOGY, 2018, 154 (06) : S402 - S402
  • [2] Perioperative Complications in Inflammatory Bowel Disease
    Beddy, David
    Dozois, Eric J.
    Pemberton, John H.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (07) : 1610 - 1619
  • [3] Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
    Poylin, Vitaliy Y.
    Serrato, Jose Cataneo
    Del Valle, Jonathan Pastrana
    Feuerstein, Joseph D.
    INTESTINAL RESEARCH, 2022, 20 (01) : 72 - 77
  • [4] INFECTIOUS COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECIEVING BIOLOGIC THERAPY
    Ochoa, C. D.
    Rajaram, P.
    Tanukonda, S.
    Sadikot, R. T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 679 - 680
  • [5] Management of Biologic Agents During Pregnancy in Patients with Inflammatory Bowel Disease
    Sheibani, Sarah
    Mahadevan, Uma
    PRACTICAL GASTROENTEROLOGY, 2013, 37 (06) : 34 - +
  • [6] Choosing the right biologic for complications of inflammatory bowel disease
    Rakowsky, Shana
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (03) : 235 - 249
  • [7] The use of biologic agents in pediatric inflammatory bowel disease
    Yang, Linda S.
    Alex, George
    Catto-Smith, Anthony G.
    CURRENT OPINION IN PEDIATRICS, 2012, 24 (05) : 609 - 614
  • [8] Use of biologic agents in pediatric inflammatory bowel disease
    Rosh, Joel R.
    CURRENT OPINION IN PEDIATRICS, 2009, 21 (05) : 646 - 650
  • [9] BIOLOGIC THERAPY PREVENTS COVID RELATED COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS
    Nanah, Rama
    Almasri, Jehad
    Eltelbany, Ahmed
    Nanah, M. Housam
    Khoudari, George
    Nanah, Robana
    Hamid, Osama
    Regueiro, Miguel D.
    GASTROENTEROLOGY, 2023, 164 (06) : S534 - S534
  • [10] Variations in disease monitoring between Inflammatory Bowel Disease patients on intravenous and subcutaneous biologic agents
    Hilley, P.
    Suen, C. Li Wai
    Srinivasan, A.
    Choy, M. C.
    De Cruz, P.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S393 - S393
12345